As key financial and digital asset leaders convene in Washington, Coinbase's Head of Global Research expresses strong confidence that the long-stalled CLARITY Act will finally pass this year, citing growing bipartisan support and institutional pressure.
Hong Kong is poised to grant its first stablecoin issuer licenses as early as March, marking a critical milestone in its bid to become a regulated digital asset hub. The HKMA's rigorous vetting process will initially see only a handful of firms approved from dozens of applicants.
While EOG Resources' stock has lagged behind its energy sector peers, a majority of analysts maintain a bullish stance, betting on the company's disciplined capital returns and operational execution to drive a potential rebound.
While tech captures headlines, a selection of energy and utility companies present a compelling case for reliable, high-yield dividend income in the coming year, backed by essential infrastructure and evolving demand drivers.
Digital asset investment products faced massive withdrawals last week, with U.S. spot Bitcoin ETFs leading the sell-off. The outflows have pushed year-to-date net redemptions past $1 billion, signaling a sharp shift in investor sentiment amid market turmoil.
Jumia Technologies' shares have skyrocketed over 244% in the past year, a stunning rally that appears disconnected from its recent financial performance. This surge highlights the complex dynamics of growth investing in emerging markets.
While tech stocks dominate AI headlines, Welltower Inc. is leveraging artificial intelligence and demographic shifts to redefine senior living and create a powerful growth engine, positioning itself as a unique beneficiary of long-term healthcare trends.
As speculative interest returns to the crypto markets, a handful of meme tokens are capturing attention with significant price movements and growing communities. Here’s a look at three assets showing notable activity in early February.
As the crypto market navigates uncertainty, Zilliqa's network upgrade, HYPE's market decoupling, and CC's sustained inflows present distinct opportunities for traders in the first week of February.
A South Korean family's paper wealth soared past $800 million after their company, L&F Co., inked a landmark battery materials deal with Tesla. Less than two years later, a quiet regulatory filing slashed the contract's value by 99.9997%, a collapse tied directly to Tesla's production struggles with its Cybertruck and 4680 battery cells.
With pharmaceutical companies increasingly deploying AI in direct-to-consumer platforms, the regulatory landscape remains fragmented. In the absence of comprehensive federal action, states are stepping in with disparate laws to address privacy and safety concerns, creating a complex compliance challenge for the industry.
The derivatives exchange is in early talks to reintroduce binary options for individual investors, aiming to capture the growing appetite for event-based wagering while staying within regulated financial markets.
In a significant policy pivot, new CFTC Chairman Michael Selig is moving to establish clearer federal oversight for crypto-linked prediction markets, withdrawing restrictive proposals and signaling closer collaboration with the SEC. Analysts see this as a potential 'greenfield' opportunity for major platforms.
A 16% quarterly bounce offers little solace for Cargojet Inc. shareholders, who have watched the stock plummet 57% over five years. While fundamentals show glimmers of strength, the air freight carrier's long-term trajectory remains a pressing concern for the market.
Buoyed by its leadership in artificial intelligence and cloud computing, Alphabet's stock has significantly outperformed major indices over the past year, with Wall Street analysts maintaining a strongly bullish consensus.
The Geely-owned electric vehicle maker Polestar has secured a major $400 million equity investment from a consortium led by Sumitomo Mitsui Banking Corporation and Standard Chartered Bank, signaling crucial financial backing as it navigates a competitive market.
Quince Therapeutics' lead candidate, eDSP, has failed to meet primary and secondary endpoints in its pivotal Phase III NEAT trial for the rare neurological disorder Ataxia-Telangiectasia (A-T), triggering a catastrophic drop in the company's share price.
For those on a fixed income, inflation isn't just an economic indicator—it's a direct assault on financial security. Experts warn that failing to plan for rising costs can halve a retiree's purchasing power over decades. Here’s a strategic guide to building a resilient portfolio.
The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.
Cleveland-based KeyCorp (KEY) is riding a wave of positive analyst sentiment following a strong earnings beat, with its stock performance significantly outpacing broader market indices. The bank's diversified model and robust capital returns are fueling optimism for sustained growth.
